Medway NHS Foundation Trust has appointed Mark Orchard as its new chief executive, bringing in an experienced NHS administrator to lead one of the more persistently troubled acute providers in England. The announcement was made on 28 May 2026, with Orchard due to formally take up the position in autumn of this year.

Orchard currently serves as group deputy chief executive across a shared leadership arrangement covering Portsmouth Hospitals University NHS Trust and the Isle of Wight NHS Trust. That role has involved managing operational and strategic decisions across two geographically distinct providers, coordinating services between a large urban acute trust on the mainland and a smaller island-based health system with its own logistical pressures. He moves from that position into sole command of Medway, a significantly different institutional context.

Medway NHS Foundation Trust serves a large and densely populated catchment area in Kent. The trust has faced persistent difficulties over a number of years, including long elective waiting times, recurring pressure on its emergency department, and financial deficits that have required repeated intervention. It is not a new entrant to difficulty: the trust has cycled through leadership changes and improvement programmes before, and the challenges Orchard inherits are well-documented within the health service.

The scale of what he is walking into is significant. Waiting time performance, emergency capacity, and financial sustainability are each complex problems individually. At Medway they have coexisted for long enough that they have become structurally embedded rather than situational. Improving one without deteriorating another requires a degree of operational discipline that has proved elusive for the trust's previous leadership teams.

His experience at Portsmouth and the Isle of Wight is considered relevant preparation. Managing services across two trusts with different profiles, patient populations, and operational pressures requires the kind of system-level thinking that a single-site role does not always demand. The expectation from those overseeing his appointment is that he brings that perspective to Medway's relationship with its regional integrated care board and the broader south-east health system.

Staff morale is another factor. Sustained institutional difficulty tends to wear on workforces, and trusts that have been under regulatory and financial pressure for extended periods often accumulate a degree of internal exhaustion that is distinct from the operational problems themselves. Orchard will need to address both simultaneously, which is a harder task than addressing either in isolation.

What his specific priorities will be once in post has not been set out in detail publicly. The broad mandate is performance stabilisation and financial viability, but the sequencing of how a new chief executive approaches those objectives at a trust with Medway's history tends to become clear only once they are inside the organisation and have assessed what the data looks like at close range.

The timing of the appointment places his arrival at Medway in the autumn, several months away. In the interim, the trust continues under its current leadership arrangements. That gap is not unusual for appointments at this level, where notice periods and transition planning typically extend over a number of months, but it does mean the period of change formally begins now while the practical handover remains some way off.

Medway is not the only NHS trust on the south coast managing sustained performance challenges, and Orchard's departure from the Portsmouth and Isle of Wight group will itself require a leadership response. How that shared arrangement is managed in his absence is a separate question for that organisation.

For Medway, the appointment signals an intention to bring in someone with cross-system experience rather than promoting internally or appointing a turnaround specialist from outside the NHS. Whether that approach produces different results from what the trust has seen before will take considerably longer than a few months to assess.